galactosamine has been researched along with Adenovirus Infections, Human in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bradford, MA; Butler, NS; Hunninghake, GW; Monick, MM; Powers, LS; Yarovinsky, TO | 1 |
1 other study(ies) available for galactosamine and Adenovirus Infections, Human
Article | Year |
---|---|
Adenoviral infection decreases mortality from lipopolysaccharide-induced liver failure via induction of TNF-alpha tolerance.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Animals; Antigens, CD; Autoantibodies; Cell Line; Disease Models, Animal; fas Receptor; Female; Galactosamine; Humans; Immune Tolerance; Injections, Intraperitoneal; Injections, Intravenous; Lipopolysaccharides; Liver; Liver Failure; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Survival Analysis; Tumor Necrosis Factor-alpha; Up-Regulation | 2003 |